Efficacy of sorafenib as adjuvant therapy to prevent early recurrence of hepatocellular carcinoma after curative surgery: A pilot study
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of sorafenib as adjuvant therapy to prevent early recurrence of hepatocellular carcinoma after curative surgery: A pilot study
Authors
Keywords
-
Journal
HEPATOLOGY RESEARCH
Volume 44, Issue 5, Pages 523-531
Publisher
Wiley
Online
2013-05-14
DOI
10.1111/hepr.12159
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria
- (2012) K.-C. Lim et al. BRITISH JOURNAL OF SURGERY
- Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update
- (2012) Shuichi Kaneko et al. HEPATOLOGY RESEARCH
- Is wider surgical margin justified for better clinical outcomes in patients with resectable hepatocellular carcinoma?
- (2012) King-Teh Lee et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Meta-analysis: the efficacy of anti-viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B-related hepatocellular carcinoma
- (2011) J. S.-W. Wong et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Microvascular Invasion Is a Better Predictor of Tumor Recurrence and Overall Survival Following Surgical Resection for Hepatocellular Carcinoma Compared to the Milan Criteria
- (2011) Kheng-Choon Lim et al. ANNALS OF SURGERY
- Recurrence-free survival more than 10 years after liver resection for hepatocellular carcinoma
- (2011) S. Eguchi et al. BRITISH JOURNAL OF SURGERY
- Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria
- (2011) S. T. Fan et al. BRITISH JOURNAL OF SURGERY
- An investigation of the effect of sorafenib on tumour growth and recurrence after liver cancer resection in nude mice independent of phosphorylated extracellular signal-regulated kinase levels
- (2011) Zheng Wang et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant Therapy after Curative Treatment for Hepatocellular Carcinoma
- (2011) Masatoshi Kudo ONCOLOGY
- Treatment of early hepatocellular carcinoma: How to predict and prevent recurrence
- (2010) Lorenzo Andreana et al. DIGESTIVE AND LIVER DISEASE
- Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model
- (2010) Yu-Xiong Feng et al. HEPATOLOGY
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approach
- (2010) Ying-Chun Shen et al. JOURNAL OF HEPATOLOGY
- Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma
- (2010) Jae Min Chun et al. JOURNAL OF SURGICAL ONCOLOGY
- Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma
- (2009) Jaw-Ching Wu et al. JOURNAL OF HEPATOLOGY
- The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes
- (2009) King-Teh Lee et al. JOURNAL OF SURGICAL ONCOLOGY
- Meta-analysis: interferon-alpha prevents the recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma
- (2009) Y. Miyake et al. JOURNAL OF VIRAL HEPATITIS
- Comparison of Recurrence of Hepatocellular Carcinoma After Resection in Patients with Cirrhosis to Its Occurrence in a Surveilled Cirrhotic Population
- (2008) Alessandro Cucchetti et al. ANNALS OF SURGICAL ONCOLOGY
- Novel advancements in the management of hepatocellular carcinoma in 2008
- (2008) Josep M. Llovet et al. JOURNAL OF HEPATOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started